ELEUTERI, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 13.485
EU - Europa 8.458
AS - Asia 4.986
SA - Sud America 668
AF - Africa 251
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 20
Totale 27.890
Nazione #
US - Stati Uniti d'America 13.079
PL - Polonia 2.151
CN - Cina 1.819
IT - Italia 1.453
SG - Singapore 1.450
RU - Federazione Russa 1.392
DE - Germania 1.172
FR - Francia 736
BR - Brasile 546
HK - Hong Kong 433
VN - Vietnam 420
GB - Regno Unito 417
CA - Canada 318
UA - Ucraina 307
FI - Finlandia 240
SE - Svezia 226
ZA - Sudafrica 165
KR - Corea 152
TR - Turchia 145
IN - India 104
JP - Giappone 94
IE - Irlanda 76
PK - Pakistan 62
NL - Olanda 58
BD - Bangladesh 50
MX - Messico 48
ES - Italia 47
AR - Argentina 45
IR - Iran 42
ID - Indonesia 33
CZ - Repubblica Ceca 30
BE - Belgio 28
IQ - Iraq 28
EG - Egitto 20
CL - Cile 19
EU - Europa 19
MA - Marocco 18
AU - Australia 17
TH - Thailandia 17
AT - Austria 15
LT - Lituania 15
UZ - Uzbekistan 15
EC - Ecuador 14
CH - Svizzera 13
DK - Danimarca 12
JO - Giordania 12
MY - Malesia 12
VE - Venezuela 12
DZ - Algeria 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
CO - Colombia 9
GR - Grecia 9
JM - Giamaica 9
AZ - Azerbaigian 8
BY - Bielorussia 8
CU - Cuba 8
RS - Serbia 8
IL - Israele 7
KE - Kenya 7
PH - Filippine 7
PS - Palestinian Territory 7
PY - Paraguay 7
SA - Arabia Saudita 7
BG - Bulgaria 6
KG - Kirghizistan 6
NP - Nepal 6
OM - Oman 6
PE - Perù 6
ET - Etiopia 5
KZ - Kazakistan 5
TN - Tunisia 5
TW - Taiwan 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GT - Guatemala 4
MO - Macao, regione amministrativa speciale della Cina 4
NO - Norvegia 4
PA - Panama 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
LU - Lussemburgo 2
LV - Lettonia 2
PT - Portogallo 2
Totale 27.859
Città #
Fairfield 1.223
Ashburn 1.177
Warsaw 1.176
Kraków 958
Woodbridge 946
Jacksonville 747
Singapore 699
Houston 648
Chandler 638
San Jose 629
Council Bluffs 557
Seattle 496
Wilmington 487
Dallas 452
Cambridge 448
Ann Arbor 436
Hong Kong 425
Boardman 340
Beijing 326
Camerino 296
Los Angeles 236
New York 207
Nanjing 206
The Dalles 194
Toronto 186
Johannesburg 158
Dearborn 155
Ho Chi Minh City 151
Seoul 147
Columbus 137
San Mateo 129
Helsinki 124
Tongling 124
Lauterbourg 113
Istanbul 110
London 108
Lawrence 102
Princeton 102
Ogden 99
Munich 87
Hanoi 86
Milan 82
Nanchang 82
Moscow 81
Santa Clara 80
Chicago 77
Buffalo 72
Dublin 72
Tokyo 71
Shanghai 68
Lachine 64
São Paulo 62
San Diego 58
Guangzhou 57
Kunming 54
Orem 51
St Louis 46
Philadelphia 45
Rome 44
Frankfurt am Main 42
Nürnberg 42
Jiaxing 41
Trieste 40
Montreal 39
Düsseldorf 38
Shenyang 38
Tianjin 35
Dong Ket 34
Washington 34
Hebei 31
Centro 30
Islamabad 30
Redondo Beach 30
Chennai 28
Brussels 27
Ardabil 26
Brooklyn 26
Denver 25
Hefei 25
Stockholm 25
Wuhan 25
Brno 24
Hangzhou 24
Pistoia 24
Redwood City 24
Augusta 23
Changsha 23
Phoenix 23
Zhengzhou 23
Amsterdam 22
Poplar 22
Castelraimondo 21
Cesenatico 21
Leawood 21
Manchester 21
Rio de Janeiro 21
Ankara 20
Turku 20
Atlanta 19
Jakarta 19
Totale 18.357
Nome #
A yeast strain associated to Anopheles mosquitoes produces a toxin able to kill malaria parasites 535
A ruthenium derivative of quercetin with enhanced cholesterol-lowering activity 464
Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels 431
SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model 418
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells 415
Interaction between wheat alpha-amylase/trypsin bi-functional inhibitor and mammalian digestive enzymes: Kinetic, equilibrium and structural characterization of binding 374
Interfering with the high-affinity interaction between wheat amylase trypsin inhibitor CM3 and toll-like receptor 4: in silico and biosensor-based studies 371
Homology Modeling and Docking Analysis of the Interaction between Polyphenols and Mammalian 20S Proteasomes. 352
Environmental pollutants directly affect the liver X receptor alpha activity: kinetic and thermodynamic characterization of binding 350
Effects of thymoquinone on isolated and cellular proteasomes 348
The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity 345
50 Hz extremely low frequency electromagnetic fields enhance protein carbonyl groups content in cancer cells: effects on proteasomal systems. 329
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 322
Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction 318
Effect of aluminum on the binding properties of alpha-chymotrypsin 316
Wheat sprout extract-induced apoptosis in human cancer cells by proteasomes modulation. 316
Antiplasmin activity of natural occurring polyphenols 308
Biosensor-based screening method for the detection of Aflatoxins B-1-G(1) 296
Crosstalk between the ubiquitin–proteasome system and autophagy in a human cellular model of Alzheimer's disease 290
Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes 288
Binding of aflatoxins to the 20S proteasome: effects on enzyme functionality and implications for oxidative stress and apoptosis 284
Acid-stable serine proteinase inhibitors in the urine of Alzheimer disease subjects. 284
Wheat sprout extract induces changes on 20S proteasomes functionality. 283
Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition 278
Essential amino acid mixtures drive cancer cells to apoptosis through proteasome inhibition and autophagy activation 276
Co-chaperonin GroES as a modulator of proteasomal activity. 275
Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. 275
Isolation and characterization of bovine thymus multicatalytic proteinase complex 270
Interplay between 20S proteasomes and prion proteins in scrapie disease. 268
Arene–Ruthenium(II) Acylpyrazolonato Complexes: Apoptosis-Promoting Effects on Human Cancer Cells 267
Identification of a Killer Toxin from Wickerhamomyces anomalus with β-Glucanase Activity 265
Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor 264
Sanguisorba minor extract suppresses plasmin-mediated mechanisms of cancer cell migration 263
Chimeric DNA/LNA-based biosensor for the rapid detection of African swine fever virus 261
Comparative evaluation of flavonoid content in assessing quality of wild and cultivated vegetables for human consumption 260
20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders 252
High-performance liquid chromatographic separation of aprotinin-like inhibitors and their determination in very small amounts. 252
Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer’s disease 250
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. 244
Flavonoids inhibit the amidolytic activity of human thrombin 244
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 243
Effect of polyphenolic compounds on the proteolytic activities of constitutive and immuno-proteasomes 242
ATP independent proteasomal degradation of NQO1 in BL cell lines 240
Pomegranate fruit components modulate human thrombin. 239
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 239
The fine-tuning of proteolytic pathways in Alzheimer's disease 239
Effects of Ghrelin on the Proteolytic Pathways of Alzheimer's Disease Neuronal Cells 239
Identification of an EGCG oxidation derivative with proteasome modulatory activity. 238
Natural polyphenols as proteasome modulators and their role as anti-cancer compounds 237
Natural occurring polyphenols as template for drug design. Focus on serine proteases. 237
The bovine lung 20S proteasome binding to reversible inhibitors: modulation by sodium ion 235
Regulation of preprotachykinin-A gene expression in an animal model of Alzheimer's disease 232
Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition 231
Development of an ELISA test for determination of the urinary trypsin inhibitor: analytical performance and applications 230
Proteinase inhibitors of the Kunitz family in fallow deer organs: a comparative study. 230
Rapid reverse phase-HPLC assay of HMG-CoA reductase activity. 230
Bioactive Ru(II)-Arene Complexes with Natural Polyphenolic Ligands as Anticancer Metallodrugs 230
Guanylin, uroguanylin and guanylate cyclase-C are expressed in the gastrointestinal tract of horses 230
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes 227
Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction. 226
Dinuclear (h6-arene) ruthenium(II) acylpyrazolone complexes: Synthesis, characterization and cytotoxicity 221
Peroxynitrite induced oxidation and its effects on isolated proteasomal systems 219
Bovine spleen Multicatalytic Proteinase Complex (Proteasome) 218
The interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization 218
Binuclear 3,3′,5,5′-tetramethyl-1H,H-4,4′-bipyrazole Ruthenium(II) complexes: Synthesis, characterization and biological studies 218
Characterization of Panax ginseng root extracts: development of a new analytical method for the quantification of ginsenosides and biological studies. 217
Kinetic and equilibrium characterization of the interaction between bovine trypsin and I-ovalbumin 215
Differences in Catalytic Activities and Subunit Pattern of Multicatalytic Proteinase Complexes (Proteasomes) Isolated from Bovine Pituitary, Lung and Liver 213
Aluminum modulation of proteolytic activities 212
A NEW FAMILIAL LEWY BODY DISEASE IN YELLOW-CROWNED AMAZON PARROTS (AMAZONA OCHROCEPHALA) 211
Reactions of 14C-3,4-Dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes) 210
Peroxynitrite-mediated oxidation of the C85S/C152E mutant of dihydrofolate reductase from Escherichia coli: functional and structural effects 209
Aflatoxin B1 misregulates the activity of serine proteases: possible implications in the toxicity of some mycotoxin. 208
Clinical Relevance of Assessing Serum Amyloid and Main Biochemical Parameters in Newborn Ragusano Donkey Foals During the First Month of Life 202
Mechanistic insights on petrosaspongiolide M inhibitory effects on immunoproteasome and autophagy 202
Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study 201
Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate. 199
Isolation and N-Terminal sequence of multiple forms of granulins in human urine 199
Ligand Design for N,O- or N,N‐Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity 199
Assessment of serum amyloid A concentrations and biochemical profiles in lactating jennies and newborn Ragusano donkey foals around parturition and one month after foaling in Sicily 198
Targeting proteasomes with natural occurring compounds in cancer treatment. 197
Protein oxidation and cellular homeostasis: Emphasis on metabolism 196
Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation 194
The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities. 191
Potent and selective ligands for adenosine binding sites 190
Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease 189
Effect of neurotoxic metal ions on the proteolytic activities of the 20S proteasome from bovine brain 186
Dinuclear Arene Ruthenium(II) Complexes with 3,3’,5,5’-Tetramethyl-4,4’-Bipyrazole and Modulation of Proteasome Activity 184
Binding of aflatoxins to the 20S proteasomes: effects on the enzyme functionality 183
Changes induced by wheat sprout extract on 20S proteasomes functionality 177
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy 176
Characterization of 20S proteasome expression and functionality in brain stem of scrapie sheeps 174
Anti-inflammatory and antioxidant activities of ginsenosides and ginseng root extract to counteract obesity 171
Flavan‐3‐ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid‐beta (1‐42) Levels 167
Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism 164
Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease 161
KLOX FLUORESCENCE BIOMODULATION SYSTEM (KFBS), AN ALTERNATIVE ADJUNCT THERAPY FOR THE MANAGEMENT OF CLINICAL MANIFESTATION OF CANINE PYODERMAS 161
Structure/activity virtual screening and in vitro testing of small molecule inhibitors of 8-hydroxy-5-deazaflavin:NADPH oxidoreductase from gut methanogenic bacteria 160
In vivo and in vitro study of phagocytic function during ovine paratubercolisis 155
Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization 155
Totale 24.915
Categoria #
all - tutte 106.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.434 174 338 48 36 55 56 83 106 91 153 140 154
2022/20231.710 200 94 75 290 185 213 16 111 265 125 89 47
2023/20241.550 176 80 121 59 85 224 45 92 133 47 33 455
2024/20254.435 128 114 356 208 150 224 563 1.130 341 306 274 641
2025/20267.028 460 432 857 945 746 552 1.049 515 312 429 456 275
2026/2027352 352 0 0 0 0 0 0 0 0 0 0 0
Totale 28.300